4
Changes in Ownership
Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-17-048535
Chief Executive Officer bought 1,695 shares at $6.00 ($10,170)
From the SEC's structured data for this filing
Trades in this filing
Cohen Yuval · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-08-11 | Purchase : show line 1 in the form | +1,695 | $6.00 | $10,170 | 57,775 | D |
| Open-market purchases · 1,695 sh · avg $6.00 · $10,170 | ||||||
Loading xslF345X03/doc4.xml…